Skip to main content
. 2024 Oct 8;14:1473706. doi: 10.3389/fonc.2024.1473706

Figure 1.

Figure 1

Recommendations for biomarker testing and immunotherapy for head and neck cancers (based on American Society of Clinical Oncology guidelines, 2022).